Men with Disrupted Sleep Routine Have High Risk of Prostate Cancer

Research discovered that men who have trouble sleeping have twice the risk of developing prostate cancer compared to those who sleep well, according to online sources. The research also expands on the growing body of evidence that men and women whose sleep is short, broken or of poor quality are at higher risk of developing wide range of cancers. The risk of prostate cancer rose by 60 percent for men who had trouble falling asleep but doubled for those who reported difficulty staying asleep. The researchers also found evidence that those with sleep problems were more likely to have advanced prostate cancer than those who slept well.
 
Higher levels of melatonin, a hormone produced at night that helps regulate the body’s internal clock, were linked to a 75 percent lower risk of developing an advanced form of the disease. Sleep loss and other factors can influence the amount of melatonin secretion or block it altogether, and health problems associated with low melatonin, disrupted sleep, and/or disruption of the circadian rhythm are broad, including a potential risk factor for cancer. Early detection of prostate cancer can be effectively prevented and treated through robotic surgery. It is a state-of-the-art technology that features a magnified 3D high-definition vision system and tiny wristed instruments that bend and rotate far greater than the human wrists. Despite its advanced technology, the system has been reported to cause side effects that prompted patients to file lawsuits against its manufacturer. You can refer at davinci-lawsuit.org for information about the complaints.
 
Men who had higher levels of melatonin had a 75 percent reduced risk for developing advanced prostate cancer compared with men who had lower melatonin. The risk was especially reduced when it came to advanced disease.
 
One in seven men reported problems falling asleep, one in five men said they had problems staying asleep, and about one in three reported taking medication to help them sleep, the study found. Men with sleep troubles had significantly lower levels of the chemical 6-sulfatoxymelatonin -- a breakdown product of melatonin -- compared to men who reported no sleeping issues.
 
However, prospective studies to investigate the interplay between sleep disturbances, sleep duration and melatonin levels on the risk of prostate cancer are still required.
 
 
References:
 

• medicinenet.com/script/main/art.asp?articlekey=176275
• telegraph.co.uk/men/active/mens-health/10582591/Sound-sleep-linked-to-lower-prostate-cancer-risk.html
• articles.latimes.com/2013/may/08/science/la-sci-sleep-disruption-cancer-risk-20130507
• medicaldaily.com/disrupted-sleep-linked-higher-prostate-cancer-risk-245643